Text Size

A A A

Search


 

Home | Clinical Trials

FDA Approved Drugs » 1996
Medical Areas: Neurology | Oncology | Family Medicine

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

UltraJect

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mallinckrodt Group
Approval Status: Approved August 1996
Treatment Area: chronic pain

General Information

The UltraJect Morphine Sulfate Injection has been approved in two dosage strengths. It is the first terminally sterilized plastic syringe intended for use with patient-controlled pain management. The injection system allows patients to dispense their own medication. Morphine sulfate is used to treat moderate to severe pain such as that associated with post-operative surgical pain or cancer.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org